Clinically, tumor tissue immunohistochemistry (IHC) staining is used to measure the protein expression of four transcription factors (ASCL1, NEUROD1, POU2F3, and YAP1) to identify SCLC subtypes. This evidence concerns the gene NEUROD1 and neoplasm.